KROS 8-K: Buyback

Filed with the SEC on · accession 0001664710-26-000072

KROS filed a 8-K (current report) with the SEC on Nov 16, 2026. Keros Therapeutics' board approved a new stock repurchase program of up to $5 million of common stock, following receipt of a $20 million development milestone payment from Takeda. The stock moved -1.8% by the first close after the filing.

Summary of the filing

Keros Therapeutics' board approved a new stock repurchase program of up to $5 million of common stock, following receipt of a $20 million development milestone payment from Takeda. The company expects its cash position to fund operations into 2029.

Key details

Stock repurchase program authorized amount$5.0M
Development milestone payment received from Takeda$20.0M
Cash and cash equivalents as of September 30, 2026$259.5M
RegistrantKeros Therapeutics, Inc.
License agreement partner; paid $20 million development milestoneTakeda Pharmaceuticals U.S.A., Inc.
Chief executive officerJasbir Seehra

How KROS stock reacted

Close before

$10.30

Nov 13, 2026

First close after

-1.84%

$10.11

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for KROS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for KROS?

Click here

Frequently asked questions

What did KROS file with the SEC on Nov 16, 2026?

KROS filed a 8-K (Buyback). Keros Therapeutics' board approved a new stock repurchase program of up to $5 million of common stock, following receipt of a $20 million development milestone payment from Takeda. The company expects its cash position to fund operations into 2029.

What does a buyback mean for KROS stock?

Usually: fewer shares means each remaining share owns more of the company. It matters whether the company actually buys and at what price.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did KROS stock react to this filing?

KROS closed at $10.30 before the filing and $10.11 on Nov 16, 2026 (-1.84%).

Other KROS SEC filings

Get alerts when KROS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days